No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Cyclin-Dependent Kinases / genetics
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / genetics
-
Lung Neoplasms / pathology
-
Male
-
Mutation
-
Neuroendocrine Tumors / drug therapy*
-
Neuroendocrine Tumors / genetics
-
Neuroendocrine Tumors / secondary
-
Paclitaxel / therapeutic use*
-
Phthalazines / therapeutic use*
-
Piperazines / therapeutic use*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Phthalazines
-
Piperazines
-
CDK12 protein, human
-
Cyclin-Dependent Kinases
-
Paclitaxel
-
olaparib